An open label randomised study comparing the role of combination of everolimus and low dose tacrolimus with full dose tacrolimus in the prevention of left ventricular hypertrophy in heart transplant recepients.

Trial Profile

An open label randomised study comparing the role of combination of everolimus and low dose tacrolimus with full dose tacrolimus in the prevention of left ventricular hypertrophy in heart transplant recepients.

Not yet recruiting
Phase of Trial: Phase 0

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Everolimus (Primary) ; Mycophenolate; Prednisolone; Tacrolimus
  • Indications Left ventricular hypertrophy
  • Focus Therapeutic Use
  • Acronyms RAD-TAC
  • Most Recent Events

    • 25 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top